Characterization and biocompatibility of organogels based on L-alanine for parenteral drug delivery implants
- PMID: 15916802
- DOI: 10.1016/j.biomaterials.2005.04.004
Characterization and biocompatibility of organogels based on L-alanine for parenteral drug delivery implants
Abstract
The development of simple and efficient drug delivery systems for the sustained release of peptides/proteins and low molecular weight hydrophilic molecules is an ongoing challenge. The purpose of this work was to prepare and characterize novel biodegradable in situ-forming implants obtained via the self-assembly of L-alanine derivatives in pharmaceutical oils. Six different amphiphilic organogelators based on L-alanine were synthesized. These derivatives could successfully gel various vegetable and synthetic oils approved for parenteral administration. Gelation was thermoreversible, and phase transition temperatures depended on gelator structure, concentration and solvent. Hydrogen bonds and van der Waals interactions were shown to be the main forces implicated in network formation. Selected formulations were then injected subcutaneously in rats for preliminary assessment of biocompatibility. Histopathological analysis of the surrounding tissues revealed mild, chronic inflammation and an overall good biocompatibility profile of the implants over the 8 wk evaluation period. This study demonstrates that in situ-forming organogels represent a potentially promising platform for sustained drug delivery.
Similar articles
-
First report on the efficacy of l-alanine-based in situ-forming implants for the long-term parenteral delivery of drugs.J Control Release. 2005 Nov 28;108(2-3):433-41. doi: 10.1016/j.jconrel.2005.08.016. Epub 2005 Sep 21. J Control Release. 2005. PMID: 16182402
-
Self-assembled L-alanine derivative organogel as in situ drug delivery implant: characterization, biodegradability, and biocompatibility.Drug Dev Ind Pharm. 2010 Dec;36(12):1511-21. doi: 10.3109/03639045.2010.488694. Epub 2010 Aug 12. Drug Dev Ind Pharm. 2010. PMID: 21050137
-
Tissue reactions of in situ formed dextran hydrogels crosslinked by stereocomplex formation after subcutaneous implantation in rats.Biomaterials. 2005 Jun;26(18):3901-9. doi: 10.1016/j.biomaterials.2004.10.008. Biomaterials. 2005. PMID: 15626437
-
Organogels in drug delivery.Expert Opin Drug Deliv. 2005 May;2(3):489-505. doi: 10.1517/17425247.2.3.489. Expert Opin Drug Deliv. 2005. PMID: 16296770 Review.
-
Organogels and their use in drug delivery--a review.J Control Release. 2008 Feb 11;125(3):179-92. doi: 10.1016/j.jconrel.2007.09.014. Epub 2007 Nov 7. J Control Release. 2008. PMID: 18082283 Review.
Cited by
-
Genetically engineered block copolymers: influence of the length and structure of the coiled-coil blocks on hydrogel self-assembly.Pharm Res. 2008 Mar;25(3):674-82. doi: 10.1007/s11095-007-9343-z. Epub 2007 Aug 23. Pharm Res. 2008. PMID: 17713844
-
Transparent Organogels as a Medium for the Light-Induced Conversion from Spiropyran to Merocyanine.Gels. 2023 Nov 27;9(12):932. doi: 10.3390/gels9120932. Gels. 2023. PMID: 38131918 Free PMC article.
-
Self-assembling Organogels Loaded with Tenoxicam for Local Intensive Pain and Inflammation Cure: In Vitro and In Vivo Correlation.AAPS PharmSciTech. 2024 Jan 23;25(1):18. doi: 10.1208/s12249-024-02742-9. AAPS PharmSciTech. 2024. PMID: 38263347
-
Self-Healing Oxalamide Organogelators of Vegetable Oil.Gels. 2023 Aug 29;9(9):699. doi: 10.3390/gels9090699. Gels. 2023. PMID: 37754380 Free PMC article.
-
Endogenous stimulus-powered antibiotic release from nanoreactors for a combination therapy of bacterial infections.Nat Commun. 2019 Oct 2;10(1):4464. doi: 10.1038/s41467-019-12233-2. Nat Commun. 2019. PMID: 31578336 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources